Please login to the form below

Not currently logged in
Email:
Password:

Astellas files lawsuit against Nycomed

Astellas has filed a patent infringement lawsuit in the US against Nycomed in relation to Protopic, an eczema medicated ointment

Japanese pharmaceutical company Astellas has filed a patent infringement lawsuit in the US against Nycomed in relation to Protopic (tacrolimus), an eczema medicated ointment.

The lawsuit has been filed as a result of Nycomed submitting an abbreviated new drug application (ANDA) to the US Food and Drug Administration (FDA) for a generic version of Protopic – Astellas' 0.1 per cent tacrolimus ointment.

Astellas filed the patent infringement action in the US District Court for the District of New Jersey on October 27, 2010. Astellas is petitioning for Nycomed's ANDA not to be approved before the expiration of two patents held by Astellas in relation to Protopic.

Protopic ointment is indicated for the treatment of moderate to severe eczema and has been approved for use in the US since the end of 2000. Protpoic is available in two dosage strengths – 0.1 per cent and 0.03 per cent. It is recommended that children aged between two and 15 years should only receive the 0.03 per cent strength of the ointment.

28th October 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Article: What's next? How behavioural science can support pharma's future
...
Video: UX/ Experience design research
...

Infographics